All In Biotech

Drug Trial Radar · NCT05357989

A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

A 6-month Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial Investigating the Efficacy, Safety, and Tolerability of Two Different Doses of Buntanetap or Placebo in Patients With Early Parkinson's Disease

Last checked: Nov 19, 2026Latest source record: Mar 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 523 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

523

Actual

Start

Aug 3, 2022

Primary completion

Dec 4, 2023

Study completion Dec 4, 2023

Sponsor

Lead sponsor
Annovis Bio Inc.Industry
Sponsor type
Industry
Collaborators
TFS Trial Form Support
First posted
May 3, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to measure safety and efficacy of buntanetap/posiphen capsules compared with placebo capsules in participants with early PD. Study details include: * The study duration will be up to 7-8 months. * The double-blind treatment duration will be up to 6 months. * There will be 5 in-clinic visits and 7 phone calls

Conditions

  • Parkinson's Disease, Idiopathic

Interventions

  • buntanetap/posiphenDrug

    HPMC (vegetarian source) capsule shells

  • PlaceboDrug

    HPMC (vegetarian source) capsule shells

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Month 6 in MDS-UPDRS Part II (OFF-state)Time frame: Baseline and 6 months visits

Locations

69 sites in 6 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham (UAB)- The Kirklin Clinic

    Birmingham, Alabama

  • Banner Sun Health Research Institute - Cleo Roberts Center for Clinical Research

    Sun City, Arizona

  • Parkinson's & Movement Disorder Institue (PMDI) - Orange County Office

    Fountain Valley, California

  • UCSF Medical Center - Parkinson's Disease and Movement Disorders Clinic

    San Francisco, California

  • Rocky Mountain Movement Disorder Center

    Englewood, Colorado

  • Ki Health Partners LLC D/B/A New England Institute for Clinical Research

    Stamford, Connecticut

  • Visionary Investigators Network

    Aventura, Florida

  • Parkinson's Disease and Movement Disorders Center of Boca Raton

    Boca Raton, Florida

  • The Neurology Institute - Coral Springs

    Coral Springs, Florida

  • Arrow Clinical trial

    Daytona Beach, Florida

  • Accel Research Sites - DeLand Clinical Research Unit

    DeLand, Florida

  • Coral Clinic Reserach LLC

    Homestead, Florida

  • Homestead Associates in Research, Inc

    Miami, Florida

  • Visionary Investigators Networks

    Miami, Florida

  • Medical Professional Clinical Research Center, INC

    Miami, Florida

  • Reliant Medical Research

    Miami, Florida

  • Ezy Medical Research Co.

    Miami, Florida

  • Visionary Investigators Network

    Miami, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Visionary Investigators Network

    Pembroke Pines, Florida

  • Parkinsons Disease Treatment Center

    Port Charlotte, Florida

  • University of South Florida (USF) - University of South Florida College of Medicine- Parkinson's Disease and Movement Disorders Center

    Tampa, Florida

  • ClinCloud, LLC

    Viera, Florida

  • Conquest Research, LLC

    Winter Park, Florida

  • CenExel iResearch, LLC

    Decatur, Georgia

  • Hawaii Pacific Neuroscience, LLC

    Honolulu, Hawaii

  • Josephson Wallack Munshower Neurology, P.C.

    Indianapolis, Indiana

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Michigan State University (MSU)- Health Team- Neurology and Ophthalmology Clinic

    East Lansing, Michigan

  • Quest Research Institue

    Farmington Hills, Michigan

  • Parkinson's Disease and Movement Disorders Center of Long Island

    Commack, New York

  • Mount Sinai West (Mount Sinai Roosevelt)

    New York, New York

  • Ohio State University Wexner Medical Center (OSUWMC) - CarePoint Gahanna

    Columbus, Ohio

  • The Movement Disorder Clinic (MDC) of Oklahoma

    Tulsa, Oklahoma

  • Abington Neurology

    Abington, Pennsylvania

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Rhode Island Hospital

    Providence, Rhode Island

  • Medical University of South Carolina (MUSC) - The Murray Center for Research on Parkinson's Disease and Related Disorders

    Charleston, South Carolina

  • Veracity Neuroscience, LLC

    Memphis, Tennessee

  • Central Texas Neurology Consultants

    Round Rock, Texas

Showing 40 of 69 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.